Insider Trades
Common-stock transactions that officers, directors and 10% owners of healthcare companies report to the SEC on Form 4, from 2006 to today, newest first.
Insider filings are public records and are not a recommendation.
Results
2 transactions, newest first
| Date | Insider | Relationship | Company | Transaction | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Pieraccini Peter | Director | Vogenx, Inc.VOGX | OtherC · Conversion of a derivative security | 42,735 | $11.70 | $499,999.50 | 42,735Indirect, See Note 1 | Form 4 filed 13 Aug 2026, on sec.gov (opens in a new tab)Filed 13 Aug 2026 | |
| DELMAR STEVEN R | Director, Chief Financial Officer | Vogenx, Inc.VOGX | OtherC · Conversion of a derivative security | 4,273 | $11.70 | $49,994.10 | 704,273Direct | Form 4 filed 13 Aug 2026, on sec.gov (opens in a new tab)Filed 13 Aug 2026 |
Source: SEC EDGAR Form 4 filings and the SEC Insider Transactions Data Sets (2006 onward). Each row links to its Form 4 filing. Values are shares times the reported price. Nothing here is investment advice.